| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/16/2010 | US20100233270 Delivery of Oligonucleotide-Functionalized Nanoparticles |
| 09/16/2010 | US20100233269 Mineralized polymer particles and the method for their production |
| 09/16/2010 | US20100233268 Powder formulations for inhalation containing enantiomerically pure beta-agonists |
| 09/16/2010 | US20100233267 Composite hydrogel |
| 09/16/2010 | US20100233266 Articles and methods of treating vascular conditions |
| 09/16/2010 | US20100233265 Matrix-type pharmaceutical solid preparation |
| 09/16/2010 | US20100233264 TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF |
| 09/16/2010 | US20100233263 Methods and compositions for treatment of lesioned sites of body vessels |
| 09/16/2010 | US20100233262 Coated tablet |
| 09/16/2010 | US20100233261 Pharmaceutical Composition Comprising Amlodipine and Losartan |
| 09/16/2010 | US20100233260 Pharmaceutical composition for oral administration |
| 09/16/2010 | US20100233259 Dosage form of ropinirole |
| 09/16/2010 | US20100233258 Tablet having concavity with active ingredient disposed therein and manufacturing method thereof |
| 09/16/2010 | US20100233257 Low dose sublingual tablets of opioid analgesics and preparation process |
| 09/16/2010 | US20100233256 Synergistic combinations for treating hypertension |
| 09/16/2010 | US20100233255 Combination of trazine derivatives and insulin secretion stimulators |
| 09/16/2010 | US20100233254 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same |
| 09/16/2010 | US20100233253 Extended release gastro-retentive oral drug delivery system for valsartan |
| 09/16/2010 | US20100233252 Low-Moisture-Content Hard Capsule and Production Method Therefor |
| 09/16/2010 | US20100233251 Vaccine Nanotechnology |
| 09/16/2010 | US20100233250 Vaccine |
| 09/16/2010 | US20100233249 Contraceptive methods and compositions related to proteasomal interference |
| 09/16/2010 | US20100233248 Clay-based hemostatic agents and devices for the delivery thereof |
| 09/16/2010 | US20100233246 Adhesive tissue repair patch and collagen sheets |
| 09/16/2010 | US20100233244 Smoking Withdrawal Combination Wafer |
| 09/16/2010 | US20100233242 Engineered proteins, and methods of making and using |
| 09/16/2010 | US20100233235 Compositions and methods for preventing cardiac arrhythmia |
| 09/16/2010 | US20100233234 System and method for a hydrogel and hydrogel composite for cartilage repair applications |
| 09/16/2010 | US20100233233 Tenocyte containing bioscaffolds and treatment using the same |
| 09/16/2010 | US20100233232 Fatty-acid based particles |
| 09/16/2010 | US20100233231 Use of cryogenic processing to obtain a substantially-thickened formulation |
| 09/16/2010 | US20100233230 Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis |
| 09/16/2010 | US20100233228 Drug-Eluting Medical Device |
| 09/16/2010 | US20100233225 Method of surface coating devices to incorporate bioactive molecules |
| 09/16/2010 | US20100233221 Stable double emulsions |
| 09/16/2010 | US20100233219 Inorganic nanoparticle compromising an active substance immobilized on the surface and a polymer |
| 09/16/2010 | US20100233218 Combination enzyme for cystic fibrosis |
| 09/16/2010 | US20100233217 Organic compounds |
| 09/16/2010 | US20100233201 Vaccine composition |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233117 Adjuvant combination formulations |
| 09/16/2010 | US20100233108 process for the preparation of inverse latex of acrylamide-based polymers and composition comprising said latex |
| 09/16/2010 | US20100233100 Amphiphilic copolymeric material |
| 09/16/2010 | US20100233099 Device for intranasal administration |
| 09/16/2010 | US20100233087 Cyp1b1 nucleic acids and methods of use |
| 09/16/2010 | US20100230845 Process of making flowable hemostatic compositions and devices containing such compositions |
| 09/16/2010 | US20100230517 Shape engineering of nanoparticles |
| 09/16/2010 | DE102010002752A1 Emulgierende Zusammensetzungen basierend auf Alkylpolyglycosiden und Estern Emulsifying compositions based on alkylpolyglycosides and esters |
| 09/16/2010 | CA2760563A1 Device for intranasal administration |
| 09/16/2010 | CA2755274A1 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| 09/16/2010 | CA2755121A1 Combination therapy with thiocolchicine derivatives |
| 09/16/2010 | CA2755116A1 Ameliorating agent for chronic obstructive pulmonary disease |
| 09/16/2010 | CA2755106A1 Complex of polymeric quaternary ammonium and anionic polymers as a new antimicrobial agent for ophthalmic compositions |
| 09/16/2010 | CA2755084A1 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 09/16/2010 | CA2755068A1 Treatment of diabetes and metabolic syndrome |
| 09/16/2010 | CA2754909A1 Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment |
| 09/16/2010 | CA2754897A1 External preparation containing analgesic/anti-inflammatory agent |
| 09/16/2010 | CA2754860A1 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
| 09/16/2010 | CA2754853A1 Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
| 09/16/2010 | CA2754623A1 Oil-based preparation containing antiprotozoal triazines and anthelmintic cyclodepsipeptides |
| 09/16/2010 | CA2754612A1 Oily suspension containing probiotic bacteria for paediatric use |
| 09/16/2010 | CA2754101A1 Medical devices comprising gel for the treatment of vascular conditions |
| 09/16/2010 | CA2753685A1 Highly compactable and durable direct compression excipients and excipient systems |
| 09/16/2010 | CA2753498A1 Plasma-adapted balanced electrolyte solution |
| 09/16/2010 | CA2752713A1 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid |
| 09/16/2010 | CA2748856A1 Riluzole aqueous suspensions |
| 09/15/2010 | EP2228421A2 Compositions containing fluorine substituted olefins |
| 09/15/2010 | EP2228066A1 Pharmaceutical compositions of sulphonylurea-based active pharmaceutical ingredient with excellent dissolution properties |
| 09/15/2010 | EP2228063A1 Loxoprofen-containing aqueous plaster |
| 09/15/2010 | EP2228061A2 Fixed oral pharmaceutical compound comprising a hydrophobic material |
| 09/15/2010 | EP2228060A1 Oral dosage forms comprising fenofibrate |
| 09/15/2010 | EP2228059A1 Chemotherapeutic composition for the treatment of cancer |
| 09/15/2010 | EP2228058A1 Anionic oil-in-water emulsion containing prostaglandins and uses thereof |
| 09/15/2010 | EP2228057A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
| 09/15/2010 | EP2228056A2 Tolperisone controlled release tablet |
| 09/15/2010 | EP2228055A1 Riluzole liquid emulsions |
| 09/15/2010 | EP2228054A1 Riluzole aqueous suspensions |
| 09/15/2010 | EP2228035A1 Use of alginate matrices to control cell growth |
| 09/15/2010 | EP2227286A1 A delivery device for administering an active substance to a subject |
| 09/15/2010 | EP2227236A2 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
| 09/15/2010 | EP2227230A1 Method for applying a polymer coating to an internal surface of a container |
| 09/15/2010 | EP2227228A2 Microstructured antimicrobial film |
| 09/15/2010 | EP2227227A1 Coating suitable for medicament contact |
| 09/15/2010 | EP2227226A2 Manufacture of tablet |
| 09/15/2010 | EP2227225A1 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release |
| 09/15/2010 | EP2227224A2 Improved pharmaceutical composition containing non-ergoline dopamine agonist and method for the preparation thereof |
| 09/15/2010 | EP2227222A2 Resuscitation fluid |
| 09/15/2010 | EP2227221A1 Effervescent tablets and effervescent granules containing carnitine tartrate |
| 09/15/2010 | EP2227216A1 Skin external preparation and method of producing the same |
| 09/15/2010 | EP2227085A1 Inhalable compositions having enhanced bioavailability |
| 09/15/2010 | EP1948710B1 Process for preparing polyhydroxyalkanoates, polymers thus obtained, compositions comprising same and use thereof |
| 09/15/2010 | EP1874282B1 Methods and compositions for treatment of cns disorders |
| 09/15/2010 | EP1845951B1 Embolization using poly-4-hydroxybutyrate particles |
| 09/15/2010 | EP1830857B1 Beclomethasone dipropionate and prednisone for reducing mortality associated with graft-versus-host disease |
| 09/15/2010 | EP1536839B1 Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus |
| 09/15/2010 | EP1536837B1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 09/15/2010 | EP1519713B1 Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect |
| 09/15/2010 | EP1467744B1 Aqueous compositions containing metronidazole |
| 09/15/2010 | EP1351681B1 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 09/15/2010 | EP1154793B1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens |